Promoter methylation status and expression of PPAR-γ gene are associated with prognosis of acute-on-chronic hepatitis B liver failure

Abstract

BackgroundPeroxisome proliferator-activated receptor gamma (PPAR-γ) has been demonstrated to be involved in anti-inflammatory reactions, but its role in acute-on-chronic hepatitis B liver failure (ACHBLF) is unclear. Therefore, DNA methylation patterns and expression level of PPAR-γ gene were detected in peripheral blood mononuclear cells (PBMCs) from 81 patients with ACHBLF, 50 patients with chronic hepatitis B (CHB), and 30 healthy controls, and the possible role of PPAR-γ in ACHBLF was analyzed.ResultsWe found that aberrant PPAR-γ promoter methylation was attenuated in ACHBLF patients compared with CHB patients and was responsible for the elevated PPAR-γ expression level, which was negatively correlated with total bilirubin and international normalized ratio. Plasma level of TNF-α and IL-6 in ACHBLF patients were higher than CHB patients and healthy controls and significantly reduced in unmethylated group. ACHBLF patients with PPAR-γ promoter methylation had poorer outcomes than those without. Correspondingly, PPAR-γ messenger RNA (mRNA) level was higher in survivors than non-survivors and gradually increased in survivors with time, while remained low level in non-survivors.ConclusionsAberrant promoter methylation decline and PPAR-γ expression rebound occurred in ACHBLF compared with CHB and could improve prognosis of ACHBLF by negatively regulating cytokines.Electronic supplementary materialThe online version of this article (doi:10.1186/s13148-015-0149-2) contains supplementary material, which is available to authorized users.

Receptor-Interacting Protein Kinase 3 (RIPK3) mRNA Levels Are Elevated in Blood Mononuclear Cells of Patients with Poor Prognosis of Acute-on-Chronic Hepatitis B Liver Failure

“…TNF-α is a cytokine involved in systemic inflammation. In fulminant liver failure, the serum level of TNF-α was significantly increased correlated with serious complications, such as infection and HE (de la Mata et al 1990;Zhao et al 2015). In the process of necroptosis, MLKL was phosphorylated and insert into the plasma membranes and organelles, which resulted in the expulsion of cellular contents into the extracellular space.…”

Expression of MMP-9 in different degrees of chronic hepatitis B and its correlation with inflammation

“…A study has revealed that MMP-9 is closely related to CHB ( 17 ). TNF-α is the first inflammatory mediator produced in the body, which plays a core role in the occurrence and development of CHB and has crucial functions in the induction of inflammatory responses, anti-infection and host defense ( 18 ). IL-6 is a kind of lymphocyte factor of acute phase reaction with diversified effects, which accelerates the proliferation of myofibroblasts and leads to liver fibrosis in CHB patients ( 19 ).…”

Design, synthesis, and biological evaluation of novel thiazolidinediones as PPARγ/FFAR1 dual agonists

“…[3][4][5] These represent a group of nuclear receptors that control cellular metabolism through the modulation of gene expression. [6] There are three distinct subtypes of PPARs: PPARα, PPARδ, and PPARγ. Activation of PPARγ has been shown to regulate glucose homeostasis, cellular differentiation, apoptosis, and inflammatory responses.…”